China National Medicines Corporation Ltd.

Shanghai Stock Exchange:600511.SS

Sector

🏥 Health Care

Industries

💊 Drugstores & Retail Pharmacies

🩺 Medical Instruments

💊 Pharmaceuticals

Location

China

Market Cap

USD 3.12 B

Share Price

USD 4.14

Avg Daily Volume

4,021,785

Change (1 day)

-0.68%

Change (1 year)

-11.36%

Change (YTD)

-11.74%

China National Medicines Corporation Ltd. EBITDA for the year ending December 31, 2024: USD 400.99 M

China National Medicines Corporation Ltd. EBITDA is USD 400.99 M for the year ending December 31, 2024, a 0.74% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

China National Medicines Corporation Ltd. EBITDA for the year ending December 31, 2023 was USD 398.03 M, a -5.43% change year over year.
China National Medicines Corporation Ltd. EBITDA for the year ending December 31, 2022 was USD 420.87 M, a 0.26% change year over year.
China National Medicines Corporation Ltd. EBITDA for the year ending December 31, 2021 was USD 419.79 M, a 27.64% change year over year.
China National Medicines Corporation Ltd. EBITDA for the year ending December 31, 2020 was USD 328.88 M, a -12.09% change year over year.